This page shows the latest Sanofi Pasteur news and features for those working in and with pharma, biotech and healthcare.
Sanofi and Translate will investigate three different dose levels of the vaccine candidate – 15µg, 45µg or 135µg. ... Sanofi Pasteur.
We have identified the path forward and remain confident and committed to bringing a safe and efficacious COVID-19 vaccine,” said Thomas Triomphe, Executive Vice President and Head of Sanofi Pasteur. ... Following the delay, Sanofi/GSK now plan to
So far, the UK has secured access to COVID-19 vaccine candidates from AstraZeneca, BioNTech/Pfizer, Novavax, Valneva, GlaxoSmithKline/Sanofi Pasteur and Janssen, as well as Moderna.
So far, the UK has secured access to potential COVID-19 vaccine candidates from AstraZeneca, BioNTech/Pfizer, Novavax, Valneva, GlaxoSmithKline/Sanofi Pasteur and Janssen, as well as Moderna.
Sanofi’s Supemtek is the now first and only recombinant influenza vaccine to be approved within the European Union. ... countries. “In the context of the COVID-19 pandemic, preventing influenza remains a public health priority,” said Thomas Triomphe
global head of Sanofi Pasteur. ... A week later, Sanofi and GSK forged another agreement with the US government for 100 million doses of their vaccine.
More from news
Approximately 13 fully matching, plus 146 partially matching documents found.
In particular the largest deal this month, between MedImmune and Sanofi Pasteur, has a headline figure of $650m, a figure which would have had the deal struggling to get into the ... Headline. $m. AstraZeneca/ MedImmune. Sanofi Pasteur. Joint Development.
Sanofi Pasteur MSD previously required upwards of nine months to bring approved commercial content to market in many of its largest markets. ... Sanofi Pasteur MSD also projects overall efficiency gains of 17% in year one and 33% annually in years two
preclinical). 225. CureVac/ Sanofi Pasteur. Exercise of option, licence. RNActive vaccine technology vs undisclosed pathogens (preclinical).
Scandinavia. CureVac's relationship with Sanofi Pasteur dates back to 2011 when the companies entered into a collaboration and option agreement covering mRNA-based vaccines generated using CureVac's RNActive technology ... Sanofi Pasteur has now
26.6. ‡SK Chemicals/ Sanofi Pasteur. Collaboration. Pneumococcal conjugate vaccine (PCV). 23. ... Japan . Outside US, Canada. ‡ Sanofi Pasteur has rights outside Korea; SK has exclusive rights for Korea.
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Carouge, who also becomes a member of Sanofi’s executive committee, will be at the helm of accelerating the transformation of the company. ... for Sanofi Pasteur since 2009.
Meanwhile, Joanna Troman (pictured left) moves to STEM as a project director following 10 years as Sanofi Pasteur MSD in a number of roles across marketing, strategic planning and market research.
Prior to Hill &Knowlton, Marchand served Sanofi, where she worked on French Parliament relations and she has held several positions within the French administration working for general secretariat for European affairs ... In her new role, Marchand will
Tarplee has over 30 years of life science industry experience and previously worked for the likes of Adherium, ALK Abello, Sanofi and Abbott. ... Lim previously worked at Novartis and Sanofi Pasteur, and most recently served at Takeda Pharmaceuticals as
He joins Portland from MHP Communications, where his two-year stint saw him rise to a senior account manager role and included a secondment to Sanofi Pasteur MSD’s comms team.
More from appointments
Approximately 1 fully matching, plus 16 partially matching documents found.
The majority of Jo’s 15 years within pharma were spent at Sanofi Pasteur MSD where she held a number of senior marketing roles before moving agency-side to STEM, holding
Sam previously held positions at Monitor and Sanofi Pasteur MSD (Merck Sharp &Dohme).
Adam Goodband joined emotive as a Strategic Planner in January 2014, having previously worked as a Medical Writer at Sanofi Pasteur MSD, has been promoted to Senior Strategic Planner.
emotive are pleased to announce the addition of former Sanofi Pasteur MSD medical writer to the team. ... Having experienced working alongside emotive as a medical writer for Sanofi Pasteur MSD, Adam was keen to join the team and bring his skills and
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...